文献速递围术期管理与 ERAS

机器人辅助与开腹根治性子宫切除术围手术期结局与恢复:RACC随机临床试验二次分析

Perioperative Outcomes and Recovery After Robot-Assisted vs Open Radical Hysterectomy: A Secondary Analysis of the RACC Randomized Clinical Trial.
PubMed 文献 · JAMA Surg · 2026-10-07

该研究为RACC多中心非劣效3期随机临床试验的预设二次分析,比较机器人辅助与开腹根治性子宫切除术的围手术期安全性和健康相关生活质量。结果显示机器人组术中并发症更少(5.7% vs 10.0%,风险差-4.3个百分点,95%CI -8.0至-0.6),术后30天并发症相似,1个月生活质量差异较小且多未达临床重要阈值。

要点

  • 机器人辅助根治性子宫切除术术中并发症发生率低于开腹手术,主要为低级别事件。
  • 两组术后30天并发症、再入院和再手术率相似。
  • 1个月生活质量差异较小,多数领域未达临床重要差异阈值。

核心结论

  • 机器人辅助根治性子宫切除术与开腹手术相比术中并发症更少,术后并发症相似,早期生活质量差异小,整体未见有临床意义的术后结局或恢复改善。

研究设计与样本

  • RACC试验为多中心、非劣效、3期随机临床试验,在欧洲三级中心开展,2019至2025年随机入组900例FIGO 2018 IB期(除外IB3)或IIA1期宫颈癌女性患者。
  • 预设二次分析纳入术中安全性分析809例(90%)、术后安全性分析798例(89%)、1个月生活质量分析723例(80%)。

主要发现

  • 术中并发症机器人组24/419例(5.7%),开腹组39/390例(10.0%),风险差-4.3个百分点(95%CI -8.0至-0.6个百分点),多数为轻微并发症,严重并发症少见且两组相似。
  • 术后30天并发症机器人组33.4%,开腹组34.8%,风险差-1.4个百分点(95%CI -7.9至5.2个百分点),包括再入院和再手术。
  • 1个月时机器人组在部分领域有小差异:躯体功能+5分(95%CI 3-8分)、角色功能+8分(95%CI 4-13分)、疼痛降低+5分(95%CI 2-9分),多数领域未达临床重要差异阈值。

临床怎么用

  • 对于早期宫颈癌需行根治性子宫切除术的患者,机器人辅助手术可减少术中并发症,但术后并发症和早期恢复与开腹手术相似。
  • 临床决策时应综合考虑肿瘤学安全性、资源可及性及患者偏好,不应仅基于围手术期结局差异选择机器人手术。

局限性

  • 预设二次分析为探索性,未针对确证性推断进行功效计算。
  • 部分分析人群未包含全部随机患者(如生活质量分析仅80%)。
  • 随访仅评估1个月生活质量,缺乏长期恢复数据。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

IMPORTANCE: Minimally invasive radical hysterectomy was introduced to reduce perioperative morbidity in early-stage cervical cancer, but concerns regarding oncologic safety have limited its use. High-quality prospective randomized data evaluating perioperative safety and recovery after robot-assisted radical hysterectomy remain limited. OBJECTIVE: To compare perioperative safety and health-related quality of life (HRQOL) after robot-assisted vs open radical hysterectomy. DESIGN, SETTING, AND PARTICIPANTS: The Robot-Assisted Approach to Cervical Cancer (RACC) trial, a multicenter, noninferiority, phase 3 randomized clinical trial, was conducted at tertiary centers in Europe. Female participants aged 18 years and older with cervical cancer (International Federation of Gynecology and Obstetrics [FIGO] 2018 stage IB [excluding IB3] or IIA1) were enrolled. Patients were randomized between 2019 and 2025. INTERVENTIONS: Robot-assisted laparoscopic radical hysterectomy. MAIN OUTCOMES AND MEASURES: Prespecified secondary outcomes included intraoperative complications (graded using standardized classification systems), postoperative complications within 30 days (Clavien-Dindo), and HRQOL at 1 month (European Organization for Research and Treatment of Cancer Quality of Life Questionnaire Core 30, European Organisation for Research and Treatment of Cancer Quality of Life Questionnaire-Cervical Cancer Module, and EuroQol 5-Dimension 3-Level questionnaire). These prespecified secondary analyses were exploratory and were not powered for confirmatory inference. RESULTS: Of 900 randomized patients (robotic surgery, median [IQR] age, 46 [39-53] years; open surgery, median [IQR] age, 45 [37-54] years), 809 (90%) were included in the intraoperative safety analysis, 798 (89%) in the postoperative safety analysis, and 723 (80%) in the 1-month HRQOL analysis. Intraoperative complications occurred in 24 of 419 patients (5.7%) in the robot-assisted group vs 39 of 390 patients (10.0%) in the open surgery group (risk difference, -4.3 percentage points; 95% CI, -8.0 to -0.6 percentage points); most were minor, whereas major complications were infrequent and similar. Postoperative complications within 30 days were similar (33.4% vs 34.8%; risk difference, -1.4 percentage points; 95% CI, -7.9 to 5.2 percentage points), including readmission and reoperation. At 1 month, robot-assisted surgery was associated with small differences in selected domains, including physical functioning (+5 points; 95% CI, 3-8 points), role functioning (+8 points; 95% CI, 4-13 points), and lower pain (+5 points; 95% CI, 2-9 points), whereas most domains did not meet thresholds for clinically important differences. CONCLUSIONS AND RELEVANCE: Results of this secondary analysis of the RACC randomized clinical trial show that robot-assisted radical hysterectomy was associated with fewer intraoperative complications, primarily reflecting lower-grade events, with similar postoperative morbidity compared with open surgery. Differences in early HRQOL were small, and overall findings indicate no improvement in clinically consequential postoperative outcomes or recovery. TRIAL REGISTRATION: ClinicalTrials.gov Identifier: NCT03719547.

来源:JAMA Surg,查看原文。版权归原作者所有。

引用

  1. Salehi S, Norberg Hardie A, Smolders RGV, et al. Perioperative Outcomes and Recovery After Robot-Assisted vs Open Radical Hysterectomy: A Secondary Analysis of the RACC Randomized Clinical Trial. JAMA Surg. 2026. PMID: 42842268. doi:10.1001/jamasurg.2026.4625

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。